# DECOR Information for Project: HL7 Italia specifiche per l’implementazione (hl7itig-)
Release V1.1 as of 2026‑04‑09 15:48:16 | | | HTML built on 2026‑04‑09 16:00:42

- Front Page
- Project Information
- Dataset
- Scenarios
- Identifiers
- Terminology
- Templates
- Issues
- Compile Time
- Legal

## Identifiers

As for now used for rendering purposes only.

### hl7ips-valueset-15 2.16.840.1.113883.11.22.15

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-15 | hl7ips-valueset-15

### hl7ips-valueset-17 2.16.840.1.113883.11.22.17

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-17 | hl7ips-valueset-17

### hl7ips-valueset-36 2.16.840.1.113883.11.22.36

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-36 | hl7ips-valueset-36

### hl7ips-valueset-9 2.16.840.1.113883.11.22.9

Language | Display Name | Description
--- | --- | ---
it-IT | hl7ips-valueset-9 | hl7ips-valueset-9

### TNM Edition8 UICC 2.16.840.1.113883.15.16

Language | Display Name | Description
--- | --- | ---
it-IT | TNM Edition8 UICC | TNM Edition8 UICC

### hl7itig-valueset-16 2.16.840.1.113883.3.1937.777.63.11.16

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-16 | hl7itig-valueset-16

### hl7itig-valueset-25 2.16.840.1.113883.3.1937.777.63.11.25

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-25 | hl7itig-valueset-25

### hl7itig-valueset-26 2.16.840.1.113883.3.1937.777.63.11.26

Language | Display Name | Description
--- | --- | ---
it-IT | hl7itig-valueset-26 | hl7itig-valueset-26

### Tipo struttura 2.16.840.1.113883.3.1937.777.63.5.1

Language | Display Name | Description
--- | --- | ---
it-IT | Tipo struttura | Tipo struttura

### AdministrativeGender 2.16.840.1.113883.5.1

Language | Display Name | Description
--- | --- | ---
it-IT | AdministrativeGender | AdministrativeGender

### HL7ActRelationshipType 2.16.840.1.113883.5.1002

Language | Display Name | Description
--- | --- | ---
it-IT | HL7ActRelationshipType | HL7ActRelationshipType

### Act Site 2.16.840.1.113883.5.1052

Language | Display Name | Description
--- | --- | ---
it-IT | Act Site | Act Site

### RoleClass 2.16.840.1.113883.5.110

Language | Display Name | Description
--- | --- | ---
it-IT | RoleClass | RoleClass

### RoleCode 2.16.840.1.113883.5.111

Language | Display Name | Description
--- | --- | ---
it-IT | RoleCode | RoleCode

### AddressUse 2.16.840.1.113883.5.1119

Language | Display Name | Description
--- | --- | ---
it-IT | AddressUse | AddressUse

### Route Of Administration 2.16.840.1.113883.5.112

Language | Display Name | Description
--- | --- | ---
it-IT | Route Of Administration | Route Of Administration

### ActStatus 2.16.840.1.113883.5.14

Language | Display Name | Description
--- | --- | ---
it-IT | ActStatus | ActStatus

### Confidentiality 2.16.840.1.113883.5.25

Language | Display Name | Description
--- | --- | ---
it-IT | Confidentiality | Confidentiality

### Act Code 2.16.840.1.113883.5.4

Language | Display Name | Description
--- | --- | ---
it-IT | Act Code | Act Code

### ActPriority 2.16.840.1.113883.5.7

Language | Display Name | Description
--- | --- | ---
it-IT | ActPriority | ActPriority

### ParticipationFunction 2.16.840.1.113883.5.88

Language | Display Name | Description
--- | --- | ---
it-IT | ParticipationFunction | ParticipationFunction

### ParticipationType 2.16.840.1.113883.5.90

Language | Display Name | Description
--- | --- | ---
it-IT | ParticipationType | ParticipationType

### Logical Observation Identifier Names and Codes 2.16.840.1.113883.6.1

Language | Display Name | Description
--- | --- | ---
it-IT | Logical Observation Identifier Names and Codes | Logical Observation Identifier Names and Codes

### ICD-9-CM 2.16.840.1.113883.6.103

Language | Display Name | Description
--- | --- | ---
it-IT | ICD-9-CM | ICD-9-CM

### Language 2.16.840.1.113883.6.121

Language | Display Name | Description
--- | --- | ---
it-IT | Language | Language

## List of Template Identifiers used in this project

Id | Display Name | Effective date | Type
--- | --- | --- | ---
2.16.840.1.113883.2.9.10.1.9.1 | Referto di Specialistica Ambulatoriale (RSA) | 2018‑04‑11 | cdadocumentlevel
2.16.840.1.113883.2.9.10.1.9.3.10 | Diagnosi (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.11 | Conclusioni (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.12 | Suggerimenti Per Il Medico Prescrittore (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.13 | Accertamenti e Controlli Consigliati (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.14 | Terapia Farmacologica Consigliata (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.3 | Allergie (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.4 | Terapia Farmacologica In Atto (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.6 | Esame Obiettivo (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.7 | Prestazioni (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.8 | Confronto Con Precedenti Esami Eseguiti (RSA) | 2018‑04‑11 | cdasectionlevel
2.16.840.1.113883.2.9.10.1.9.3.9 | Referto (RSA) | 2018‑04‑11 | cdasectionlevel
hl7itig-template-1012 | CDA place (RSA) | 2026‑03‑24 12:05:58 | cdaheaderlevel
hl7itig-template-1016 | CDA Organization RSA | 2026‑03‑24 15:08:57 | cdaheaderlevel
hl7itig-template-1017 | CDA organizationPartOf (RSA) | 2026‑03‑24 15:17:00 | cdaheaderlevel
hl7itig-template-1019 | Grado di parentela (RSA) | 2026‑03‑25 12:22:12 | cdaentrylevel
hl7itig-template-1021 | Età Insorgenza (RSA) | 2026‑03‑25 12:56:03 | cdaentrylevel
hl7itig-template-1022 | Età decesso (RSA) | 2026‑03‑25 13:04:53 | cdaentrylevel
hl7itig-template-1023 | Descrizione Agente RSA | 2026‑03‑25 15:05:50 | cdaentrylevel
hl7itig-template-1024 | playingEntity - Agente RSA | 2026‑03‑25 15:11:18 | cdaentrylevel
hl7itig-template-1025 | Descrizione Reazione RSA | 2026‑03‑25 15:22:17 | cdaentrylevel
hl7itig-template-1026 | Descrizione Criticità RSA | 2026‑03‑25 15:31:14 | cdaentrylevel
hl7itig-template-1027 | Stato dell'Allergia/Intolleranza RSA | 2026‑03‑25 15:39:42 | cdaentrylevel
hl7itig-template-1028 | Commenti RSA | 2026‑03‑25 15:45:52 | cdaentrylevel
hl7itig-template-1029 | Dettaglio terapia (RSA) | 2026‑03‑25 16:25:33 | cdaentrylevel
hl7itig-template-1030 | Precedenti esami eseguti observation (RSA) | 2026‑03‑26 09:34:52 | cdaentrylevel
hl7itig-template-1031 | Precedenti Esami Eseguiti (RSA) | 2026‑03‑26 09:57:10 | cdasectionlevel
hl7itig-template-1032 | Observation Prestazioni (RSA) | 2026‑03‑26 10:25:37 | notype
hl7itig-template-1033 | Terap Farm - Grammatura (Observation) (RSA) | 2026‑03‑26 15:23:39 | cdaentrylevel
hl7itig-template-1034 | Terapie Farmacologiche Dimissione (manufacturedProduct) (RSA) | 2026‑03‑26 15:34:18 | cdaentrylevel
hl7itig-template-1035 | Terapie Farmacologiche Dimissione (manufacturedMaterial) (RSA) | 2026‑03‑26 15:37:44 | cdaentrylevel
hl7itig-template-1036 | Terap Farm - Quantità (Observation) (RSA) | 2026‑03‑26 15:57:30 | cdaentrylevel
hl7itig-template-1037 | Supply (RSA) | 2026‑03‑26 16:01:03 | cdaentrylevel
hl7itig-template-1038 | Dettaglio Anamnesi Familiare (RSA) | 2026‑03‑27 10:08:59 | cdaentrylevel
hl7itig-template-1039 | Anamnesi Familiare (RSA) | 2026‑03‑27 10:11:24 | cdaentrylevel
hl7itig-template-1040 | Storia Clinica (RSA) | 2026‑03‑27 10:13:34 | cdasectionlevel
hl7itig-template-1041 | Quesito Diagnostico (RSA) | 2026‑03‑27 10:16:39 | cdasectionlevel
hl7itig-template-136 | Cronicità della patologia | 2022‑09‑21 15:09:38 | cdaentrylevel
hl7itig-template-137 | Stato clinico del problema | 2022‑09‑21 15:51:49 | cdaentrylevel
hl7itig-template-363 | CDA recordTargetRSA | 2023‑11‑20 14:30:55 | cdaheaderlevel
hl7itig-template-364 | CDA author RSA | 2023‑11‑20 15:01:04 | cdaheaderlevel
hl7itig-template-365 | CDA dataEntererRSA | 2023‑11‑22 15:31:43 | cdaheaderlevel
hl7itig-template-366 | CDA custodian RSA | 2023‑11‑22 16:11:13 | cdaheaderlevel
hl7itig-template-367 | CDA legalAuthenticator RSA | 2023‑11‑22 17:03:24 | cdaheaderlevel
hl7itig-template-368 | CDA participant RSA | 2023‑11‑22 17:28:50 | cdaheaderlevel
hl7itig-template-369 | CDA inFulfillmentOf RSA | 2023‑11‑22 17:50:06 | cdaheaderlevel
hl7itig-template-371 | CDA documentationOf RSA | 2023‑12‑17 11:22:50 | cdaheaderlevel
hl7itig-template-372 | CDA relatedDocument RSA | 2023‑12‑17 11:51:46 | cdaheaderlevel
hl7itig-template-373 | CDA componentOf RSA | 2023‑12‑17 12:01:37 | cdaheaderlevel
hl7itig-template-375 | Anamnesi Fisiologica-Patologica (RSA) | 2023‑12‑18 10:23:24 | cdaentrylevel
hl7itig-template-378 | Allergie - observation (RSA) | 2023‑12‑18 13:18:07 | cdaentrylevel
hl7itig-template-379 | Allergie - act (RSA) | 2023‑12‑18 14:45:57 | cdaentrylevel
hl7itig-template-385 | Participant Medico Consulente (RSA) | 2023‑12‑20 13:07:19 | cdaentrylevel
hl7itig-template-388 | Terapie Farmacologiche_SubstanceAdministration (RSA) | 2023‑12‑20 15:19:17 | cdaentrylevel
hl7itig-template-392 | Act prestazioni (RSA) | 2023‑12‑20 17:51:11 | cdaentrylevel
hl7itig-template-393 | Act Procedure (RSA) | 2023‑12‑20 18:44:24 | cdaentrylevel
hl7itig-template-395 | Participant Prestazione (RSA) | 2023‑12‑21 11:06:16 | notype
hl7itig-template-397 | Nota Prestazioni (RSA) | 2023‑12‑21 11:43:22 | clinicalstatementlevel
hl7itig-template-398 | Act_substanceAdministration (RSA) | 2023‑12‑21 12:24:51 | clinicalstatementlevel
hl7itig-template-400 | Act observation (RSA) | 2023‑12‑21 12:44:21 | cdaentrylevel
hl7itig-template-401 | Act_act_RSA | 2023‑12‑21 12:59:17 | notype
hl7itig-template-61 | CDA person (Pr) | 2022‑07‑05 09:58:26 | cdaheaderlevel
hl7itig-template-890 | CDA Organization v1.0 | 2025‑12‑18 11:14:29 | cdaheaderlevel
hl7itig-template-891 | CDA person v1.0 | 2025‑12‑18 11:16:24 | cdaheaderlevel
hl7itig-template-892 | CDA addr v1.0 | 2025‑12‑18 11:17:45 | cdaheaderlevel
hl7itig-template-893 | CDA name v1.0 | 2025‑12‑18 11:19:25 | cdaheaderlevel
hl7itig-template-894 | CDA AssignedEntity v1.0 | 2025‑12‑18 11:23:33 | cdaheaderlevel cdaentrylevel
hl7itig-template-897 | CDA organizationPartOf v1.0 | 2025‑12‑18 11:53:37 | cdaheaderlevel
hl7itig-template-912 | CDA AddressBirthPlace v1.0 | 2026‑02‑03 12:48:00 | cdaheaderlevel
hl7itig-template-987 | CDA assignedAuthoringDevice | 2026‑03‑23 15:31:00 | cdaheaderlevel
hl7itig-template-988 | MaintainedEntity | 2026‑03‑23 15:33:00 | cdaheaderlevel
hl7itig-template-991 | CDA assignedCustodian_v1.0 | 2026‑03‑23 15:47:55 | cdaheaderlevel
hl7itig-template-992 | custodianOrganization_v1.0 | 2026‑03‑23 15:48:42 | cdaheaderlevel cdaentrylevel

## List of Value Set Identifiers used in this project

Id | Display Name | Effective date
--- | --- | ---
2.16.840.1.113883.1.11.13955 | ActEncounterCode | 2017‑12‑17
2.16.840.1.113883.1.11.15933 | ActStatus | 2014‑03‑26
hl7itig-valueset-10 | X_ActStatusActiveSuspendedAbortedCompleted | 2022‑09‑25 13:39:28
2.16.840.1.113883.5.1119 | AddressUse | 2022‑11‑10
2.16.840.1.113883.1.11.1 | AdministrativeGender | 2014‑03‑26
hl7itig-valueset-56 | AllergenNoDrugs_PSSIT | 2024‑03‑14 11:43:25
2.16.840.1.113883.2.9.5.1.4 | Estensione Vocabolario ActCode | 2023‑12‑15 16:36:19
hl7itig-valueset-42 | EtaInsorgenza_PSSIT | 2024‑02‑13 11:47:09
2.16.840.1.113883.5.7 | HL7 ActPriority | 2023‑12‑15 16:12:35
2.16.840.1.113883.1.11.11526 | HumanLanguage | 2014‑03‑26
2.16.840.1.113883.1.11.10267 | ParticipationFunction | 2014‑03‑26
2.16.840.1.113883.1.11.10901 | ParticipationType | 2014‑03‑26
hl7itig-valueset-41 | ProblemCronicity_PSSIT | 2024‑02‑13 09:39:16
hl7itig-valueset-53 | ProblemObservation_PSSIT | 2024‑02‑28 12:03:14
2.16.840.1.113883.1.11.19313 | RoleClassAssociative | 2014‑03‑26
2.16.840.1.113883.1.11.14581 | RouteOfAdministration | 2014‑03‑26
2.16.840.1.113883.1.11.17660 | ServiceDeliveryLocationRoleType | 2014‑03‑26
hl7itig-valueset-55 | StatoClinicoProblema_PSSIT | 2024‑03‑12 15:54:58
2.16.840.1.113883.1.11.11610 | x_ActRelationshipDocument | 2014‑03‑26
2.16.840.1.113883.1.11.19446 | x_ActRelationshipEntry | 2014‑03‑26
2.16.840.1.113883.1.11.19447 | x_ActRelationshipEntryRelationship | 2014‑03‑26
2.16.840.1.113883.1.11.16926 | x_BasicConfidentialityKind | 2014‑03‑26

Datasets, codes, OIDs and Rules: this information is used for rendering and validation purposes.